Rationale

The upgrade in the long-term rating of Dr. D. Y. Patil Vidyapeeth Society (DDYPVS) factors in the sustained improvement in its scale of operations, robust surplus generation and a strong liquidity position, supported by consistently high occupancy levels across flagship programmes and a well-established academic reputation. The high occupancy levels leading to consistent scale benefits are expected to continue, coupled with robust liquidity profile. The upgrade also reflects the society’s demonstrated ability to fund moderate-to-large capital expenditure through internal accruals, while maintaining a debt-free capital structure and robust financial risk profile. The ratings derive comfort from the society’s self-financed, deemed-to-be-university status, which provides significant operational and financial flexibility in terms of intake capacity, course additions, fee structure, and academic design. All ongoing and planned capital expenditure, including the medium-term plan to set up a cancer hospital (Rs. 500-600 crore capex), is expected to be funded entirely through internal accruals, thereby limiting leverage risks. The society’s revenues grew at a healthy CAGR of ~20% over FY2023-2025 to ~Rs. 1,254 crore in FY2025, driven by high enrolment levels, expansion in online and distance learning programmes, and regular fee revisions. Occupancy levels in flagship MBBS, BDS and MS/MD1 programmes consistently remained strong at 92-100% in FY2025 and YTD FY2026, providing high visibility of cash flows. The society’s academic standing continues to strengthen, as reflected in its improvement in NIRF2 rankings (Dental: 4th; Medical: 12th; University: 41st, in 2025), supporting demand sustainability and its ability to command competitive fees. The operating surplus remains healthy, with margins ranging within 19-23% and core return on capital employed (core RoCE) above 45% in the last three years. The society’s financial profile is further aided by a comfortable capital structure, with no external debt since FY2022 and strong coverage indicators. The ratings, however, remain constrained by the society’s exposure to geographical and revenue concentration risks, with operations concentrated in Maharashtra and a sizeable share of revenues (~51% in FY2025) derived from the medical and dental colleges. Inherent to the education sector, it remains exposed to regulatory risks and competition inherent in the medical education sector (for both the quality of students and faculty) and seasonal irregularities in cash flows linked to admission cycles. These risks are mitigated by the long operating track record, strong brand strength, healthy demand-supply dynamics in medical education, and substantial liquidity buffers. ICRA notes that the society is planning to incur a sizeable capex of Rs. 500-600 crore in the near to medium term towards setting up of a new cancer hospital. It also purchased land parcels (for a consideration of nearly Rs. 200 crore) in YTD FY2026 to develop/expand new colleges and facilities over the next four-five years. While these will expose it to project execution and ramp-up risks, comfort can be drawn from the society’s strong liquidity position and expected healthy cash flow generation, which is likely to limit its dependence on external debt The Stable outlook reflects ICRA’s expectation that DDYPVS will benefit from healthy enrolments, steady cash flow generation, and a strong liquidity cushion, which should support its financial profile and limit reliance on external debt over the medium term.